QUANTITATIVE STRUCTURE-PHARMACOKINETIC RELATIONSHIPS (QSPR) OF BETA-BLOCKERS DERIVED USING NEURAL NETWORKS

被引:54
作者
GOBBURU, JVS [1 ]
SHELVER, WH [1 ]
机构
[1] N DAKOTA STATE UNIV,DEPT PHARMACEUT SCI,FARGO,ND 58105
关键词
D O I
10.1002/jps.2600840715
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This study demonstrates the application of neural networks to predict the pharmacokinetic properties of beta-adrenoreceptor antagonists in humans. A congeneric series of 10 beta-blockers, whose critical pharmacokinetic parameters are well established, was selected for the study. An appropriate neural network system was constructed and tested for its ability to predict the pharmacokinetic parameters from the octanol/water partition coefficient (shake flask method), the pK(a), or the fraction bound to plasma proteins. Neural networks successfully trained and the predicted pharmacokinetic values agreed well with the experimental Values (average difference = 8%). The neural network-predicted Values showed better agreement with the experimental values than those predicted by multiple regression techniques (average difference = 47%). Because the neural networks had a large number of connections, two tests were conducted to determine if the networks were memorizing rather than generalizing. The ''leave-one-out'' method verified the generalization of the networks by demonstrating that any of the compounds could be deleted from the training set and its value correctly predicted by the new network (average error = 19%). The second test involved the prediction of pharmacokinetic properties of compounds never seen by the network, and reasonable results were obtained for three out of four compounds tested. The results indicate neural networks can be a powerful tool in exploration of quantitative structure-pharmacokinetic relationships.
引用
收藏
页码:862 / 865
页数:4
相关论文
共 14 条
[1]   APPLICATIONS OF NEURAL NETWORKS IN QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS OF DIHYDROFOLATE-REDUCTASE INHIBITORS [J].
ANDREA, TA ;
KALAYEH, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (09) :2824-2836
[2]   NEURAL NETWORKS APPLIED TO PHARMACEUTICAL PROBLEMS .3. NEURAL NETWORKS APPLIED TO QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP ANALYSIS [J].
AOYAMA, T ;
SUZUKI, Y ;
ICHIKAWA, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (09) :2583-2590
[3]   NEURAL NETWORKS APPLIED TO STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
AOYAMA, T ;
SUZUKI, Y ;
ICHIKAWA, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (03) :905-908
[4]   FEEDFORWARD NEURAL NETWORKS IN CHEMISTRY - MATHEMATICAL SYSTEMS FOR CLASSIFICATION AND PATTERN-RECOGNITION [J].
BURNS, JA ;
WHITESIDES, GM .
CHEMICAL REVIEWS, 1993, 93 (08) :2583-2601
[5]  
CRAIG WA, 1976, CLIN PHARMACOKINET, V2, P252
[6]   INTRODUCTION TO BACKPROPAGATION NEURAL NETWORK COMPUTATION [J].
ERB, RJ .
PHARMACEUTICAL RESEARCH, 1993, 10 (02) :165-170
[7]   QUANTITATIVE STRUCTURE PHARMACOKINETIC RELATIONSHIPS FOR SYSTEMIC DRUG DISTRIBUTION KINETICS NOT CONFINED TO A CONGENERIC SERIES [J].
HERMAN, RA ;
VENGPEDERSEN, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (03) :423-428
[8]   QUANTITATIVE RELATIONSHIPS BETWEEN STRUCTURE AND PHARMACOKINETICS OF BETA-ADRENOCEPTOR BLOCKING-AGENTS IN MAN [J].
HINDERLING, PH ;
SCHMIDLIN, O ;
SEYDEL, JK .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1984, 12 (03) :263-287
[9]  
HINDERLING PH, 1984, J PHARMACOKINET BIOP, V12, P659, DOI 10.1007/BF01059560
[10]   PLASMA AND TISSUE PROTEIN-BINDING OF DRUGS IN PHARMACOKINETICS [J].
JUSKO, WJ ;
GRETCH, M .
DRUG METABOLISM REVIEWS, 1976, 5 (01) :43-140